Abstract
A 31-year-old woman, having a type-1 diabetes and an insulin allergy, was successfully treated with a subcutaneous antihistamine injection to the next continuous subcutaneous insulin infusion site.
MeSH terms
-
Adult
-
Diabetes Mellitus, Type 1 / drug therapy*
-
Diabetes Mellitus, Type 1 / immunology
-
Drug Hypersensitivity / drug therapy*
-
Drug Hypersensitivity / pathology
-
Female
-
Histamine Antagonists / administration & dosage
-
Histamine Antagonists / therapeutic use*
-
Humans
-
Injections, Subcutaneous
-
Insulin / adverse effects*
-
Pruritus / chemically induced
-
Pruritus / drug therapy
-
Pruritus / pathology
-
Recombinant Proteins / adverse effects*
-
Skin / drug effects
-
Skin / immunology
-
Skin / pathology
Substances
-
Histamine Antagonists
-
Insulin
-
Recombinant Proteins